EC Number | Cloned (Comment) | Organism |
---|---|---|
6.3.2.1 | gene panC, recombinant His6-tagged enzyme expression in Escherichia coli strain BL21(DE3) | Mycobacterium tuberculosis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
6.3.2.1 | crystal structure analysis of the enzyme co-crystallized with (2-[(1-benzofuran-2-yl-sulfonyl)carbamoyl]-5-methoxy-1H-indol-1-yl)acetic acid, PDB ID 3IVX, determined at a resolution of 1.73 A, and usage of the structure for enzyme-ligand binding structure predictions in molecular docking | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.1 | (4R)-2-[(2-anilinoprop-2-en-1-yl)sulfanyl]-4-(4-methoxyphenyl)-6-oxo-1,4,5,6-tetrahydropyridine-3-carbonitrile | - |
Mycobacterium tuberculosis | |
6.3.2.1 | 2-(4-bromophenyl)-2-oxoethyl 2-[4-[2-(4-bromophenyl)-2-oxoethoxy]-4-oxobutanamido]benzoate | - |
Mycobacterium tuberculosis | |
6.3.2.1 | 2-[(2Z)-2-[(5-8[(benzenesulfonyl)amino]methyl]furan-2-yl)methylidene]hydrazinyl]-N-(4-ethoxyphenyl)-2-oxoacetamide | - |
Mycobacterium tuberculosis | |
6.3.2.1 | 3-[(R)-[1-(2-methoxyethyl)-1H-tetrazol-5-yl][4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-8-methylquinolin-2(1H)-one | - |
Mycobacterium tuberculosis | |
6.3.2.1 | 3-[[4-(1,3-benzothiazol-2-yl)piperazin-1-yl][1-(2-methoxyethyl)-1H-tetrazol-5-yl]methyl]-8-methyl-3,4-dihydroquinolin-2(1H)-one | - |
Mycobacterium tuberculosis | |
6.3.2.1 | 4-(4-chlorobenzoyl)-3-hydroxy-1-[3-(1H-imidazol-1-yl)propyl]-5-[(2R)-oxolan-2-yl]-1,5-dihydro-2H-pyrrol-2-one | - |
Mycobacterium tuberculosis | |
6.3.2.1 | 7-[(2S)-2-hydroxy-3-(4-methoxyphenoxy)propyl]-3-methyl-8-[[(2Z)-2-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)hydrazinyl]methyl]-3,7-dihydro-1H-purine-2,6-dione | - |
Mycobacterium tuberculosis | |
6.3.2.1 | 7-[(R)-[4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl][4-(2-methoxyethyl)-4H-1,2,4-triazol-3-yl]methyl]-7,8-dihydro-2H-[1,3]dioxolo[4,5-g]quinolin-6(5H)-one | - |
Mycobacterium tuberculosis | |
6.3.2.1 | benzyl (1-[[1-hydrazinyl-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl)carbamate | - |
Mycobacterium tuberculosis | |
6.3.2.1 | methyl 4-(2-[[(naphthalen-1-yl)oxy]acetyl]hydrazinesulfonyl)benzoate | - |
Mycobacterium tuberculosis | |
6.3.2.1 | additional information | development of inhibitors active against the enzyme using energy based pharmacophore modeling of the available protein-inhibitor complex (3IVX) and virtual screening of a large commercial library. The e-pharmacophore model consists of a ring aromatic, negative ionizable, and acceptor sites. Inhibitor structure optimization, molecular docking. Determinations of MIC values and cytotoxicity against HEK-293 cells for the inhibitors, overview | Mycobacterium tuberculosis | |
6.3.2.1 | N-(3-benzamidobenzoyl)tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[2-(4-methylbenzamido)benzoyl]-D-tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-(2-chlorobenzamido)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-(2-fluorobenzamido)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-(3-chlorobenzamido)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-(3-nitrobenzamido)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-(4-chlorobenzamido)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-(4-fluorobenzamido)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-(4-nitrobenzamido)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-(4-tert-butylbenzamido)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-([[(furan-2-yl)oxy]carbonyl]amino)benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-[(cyclohexanecarbonyl)amino]benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-[(cyclopentanecarbonyl)amino]benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-[(pyrazine-2-carbonyl)amino]benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-[(thiophene-2-carbonyl)amino]benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-[2-(4-methoxyphenyl)acetamido]benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[3-[2-(trifluoromethyl)benzamido]benzoyl]tryptophan | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[4-[(2-[(2E)-2-[(3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl)(2-phenylethyl)sulfamoyl]phenyl]acetamide | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N-[7-[(2S)-3-(4-chlorophenoxy)-2-hydroxypropyl]-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]-D-alanine | - |
Mycobacterium tuberculosis | |
6.3.2.1 | N1-[(furan-2-yl)methyl]-N2-([3-[(3-[[(furan-2-yl)methyl]amino]-2,3-dioxopropyl)amino]phenyl]methyl)ethanediamide | - |
Mycobacterium tuberculosis |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.1 | Mg2+ | required | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.2.1 | ATP + (R)-pantoate + beta-alanine | Mycobacterium tuberculosis | - |
AMP + diphosphate + (R)-pantothenate | - |
? | |
6.3.2.1 | ATP + (R)-pantoate + beta-alanine | Mycobacterium tuberculosis ATCC 25618 / H37Rv | - |
AMP + diphosphate + (R)-pantothenate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.3.2.1 | Mycobacterium tuberculosis | P9WIL5 | - |
- |
6.3.2.1 | Mycobacterium tuberculosis ATCC 25618 / H37Rv | P9WIL5 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
6.3.2.1 | recombinant His6-tagged enzyme from Escherichia coli strain BL21(DE3) by nickel affinity chromatography | Mycobacterium tuberculosis |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.2.1 | ATP + (R)-pantoate + beta-alanine | - |
Mycobacterium tuberculosis | AMP + diphosphate + (R)-pantothenate | - |
? | |
6.3.2.1 | ATP + (R)-pantoate + beta-alanine | - |
Mycobacterium tuberculosis ATCC 25618 / H37Rv | AMP + diphosphate + (R)-pantothenate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.3.2.1 | PanC | - |
Mycobacterium tuberculosis |
6.3.2.1 | pantothenate | - |
Mycobacterium tuberculosis |
6.3.2.1 | synthetase | - |
Mycobacterium tuberculosis |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
6.3.2.1 | 37 | - |
assay at | Mycobacterium tuberculosis |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
6.3.2.1 | 7.8 | - |
assay at | Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.1 | ATP | - |
Mycobacterium tuberculosis |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
6.3.2.1 | 0.00228 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-(4-fluorobenzamido)benzoyl]tryptophan | |
6.3.2.1 | 0.00288 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-(3-nitrobenzamido)benzoyl]tryptophan | |
6.3.2.1 | 0.00359 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-(3-benzamidobenzoyl)tryptophan | |
6.3.2.1 | 0.00445 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-(4-tert-butylbenzamido)benzoyl]tryptophan | |
6.3.2.1 | 0.00521 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-(4-chlorobenzamido)benzoyl]tryptophan | |
6.3.2.1 | 0.00562 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-(2-fluorobenzamido)benzoyl]tryptophan | |
6.3.2.1 | 0.00682 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-([[(furan-2-yl)oxy]carbonyl]amino)benzoyl]tryptophan | |
6.3.2.1 | 0.00714 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-[(cyclopentanecarbonyl)amino]benzoyl]tryptophan | |
6.3.2.1 | 0.00774 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-[(cyclohexanecarbonyl)amino]benzoyl]tryptophan | |
6.3.2.1 | 0.00852 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-[2-(trifluoromethyl)benzamido]benzoyl]tryptophan | |
6.3.2.1 | 0.0093 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-[(thiophene-2-carbonyl)amino]benzoyl]tryptophan | |
6.3.2.1 | 0.00954 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-(4-nitrobenzamido)benzoyl]tryptophan | |
6.3.2.1 | 0.01006 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-(2-chlorobenzamido)benzoyl]tryptophan | |
6.3.2.1 | 0.01068 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-[(pyrazine-2-carbonyl)amino]benzoyl]tryptophan | |
6.3.2.1 | 0.01087 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-(3-chlorobenzamido)benzoyl]tryptophan | |
6.3.2.1 | 0.01563 | - |
pH 7.8, 37°C, recombinant enzyme | Mycobacterium tuberculosis | N-[3-[2-(4-methoxyphenyl)acetamido]benzoyl]tryptophan |
EC Number | General Information | Comment | Organism |
---|---|---|---|
6.3.2.1 | metabolism | the pantothenate synthetase is involved in the pantothenate biosynthetic pathway | Mycobacterium tuberculosis |
6.3.2.1 | physiological function | pantothenate synthetase, an enzyme that is involved in the pantothenate biosynthetic pathway, is essential for the virulence and persistent growth of Mycobacterium tuberculosis | Mycobacterium tuberculosis |